MAB6741-100

antibody from R&D Systems

Targeting: IGFBP2 IBP2

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Antibody Data

Product number

MAB6741-100

Provider

R&D Systems

Product name

Human IGFBP-2 Antibody

Antibody type

Monoclonal

Description

Protein A or G purified from hybridoma culture supernatant. Detects human IGFBP-2 in direct ELISAs and Western blots. In Western blots, shows less than 1% cross-reactivity with rhIGFBP-1, rhIGFBP-3, rhIGFBP-4, rhIGFBP-5, and rhIGFBP-6.

Reactivity

Human

Host

Mouse

Conjugate

Unconjugated

Antigen sequence

CAA34373


Isotype

IgG

Antibody clone number

92326

Vial size

100 ug

Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.

References

Submitted references

Deregulation of IGF-binding proteins -2 and -5 contributes to the development of endocrine resistant breast cancer in vitro.

Hawsawi Y, Humphries MP, Wright A, Berwick A, Shires M, Al-Kharobi H, El-Gendy R, Jove M, Twelves C, Speirs V, Beattie J
Oncotarget 2016 May 31;7(22):32129-43

---

Noninvasive detection of acute and chronic injuries in human renal transplant by elevation of multiple cytokines/chemokines in urine.

Hu H, Kwun J, Aizenstein BD, Knechtle SJ
Transplantation 2009 Jun 27;87(12):1814-20

---

Matrix metalloproteinase-7 degrades all insulin-like growth factor binding proteins and facilitates insulin-like growth factor bioavailability.

Nakamura M, Miyamoto S, Maeda H, Ishii G, Hasebe T, Chiba T, Asaka M, Ochiai A
Biochemical and biophysical research communications 2005 Aug 5;333(3):1011-6